Justin Boggs is a writer for the E.W. Scripps company. Justin covers anything from politics to sports and entertainment.
Moderna said it has administered its first dose in a Phase 3 trial of a combination COVID-19 and influenza shot, mRNA‐1083, which the company hopes can garner final regulatory approval by 2025.
The company says that combining the COVID-19 and flu vaccines has the potential to lead to increased compliance with vaccine recommendations. Moderna also says that having one shot instead of two would increase vaccine coverage rates by making it more convenient for patients.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Could you soon give yourself or your child a flu vaccine?Justin Boggs is a writer for the E.W. Scripps company. Justin covers anything from politics to sports and entertainment.
Read more »
How did part of the moon become a near-Earth asteroid?Justin Boggs is a writer for the E.W. Scripps company. Justin covers anything from politics to sports and entertainment.
Read more »
Personal devices, loud environments causing children to lose hearingJustin Boggs is a writer for the E.W. Scripps company. Justin covers anything from politics to sports and entertainment.
Read more »
Feds take action against makers of 'invisible mask' to prevent COVIDJustin Boggs is a writer for the E.W. Scripps company. Justin covers anything from politics to sports and entertainment.
Read more »
More health care workers burned out, facing harassment, data showsJustin Boggs is a writer for the E.W. Scripps company. Justin covers anything from politics to sports and entertainment.
Read more »
305,000 student loan borrowers incorrectly billed as payments resumeJustin Boggs is a writer for the E.W. Scripps company. Justin covers anything from politics to sports and entertainment.
Read more »